Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-000586
Filing Date
2021-04-09
Accepted
2021-04-09 17:25:05
Documents
1
Period of Report
2021-04-07

Document Format Files

Seq Description Document Type Size
1 gudin_fm4april72021.html 4  
1 gudin_fm4april72021.xml 4 3874
  Complete submission text file 0000905718-21-000586.txt   5326
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

EIN.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIRPAX PHARMACEUTICALS, INC. 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address
Gudin Jeffrey (Reporting) CIK: 0001818449 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40064 | Film No.: 21818641